| # | Drug | Count |
|---|---|---|
| 0 | FAM-TRASTUZUMAB DERUXTECAN-NXKI | 2 |
| 1 | FLUOROURACIL | 2 |
| 2 | FLUOROURACIL CREAM, 0.5% | 2 |
| 3 | OMEPRAZOLE | 2 |
| 4 | OMEPRAZOLE MAGNESIUM | 2 |
| 5 | POTASSIUM CHLORIDE | 2 |
| 6 | POTASSIUM CHLORIDE EXTENDED-RELEASE | 2 |
| 7 | POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE | 2 |
| 8 | (SALINE) | 1 |
| 9 | BENDAMUSTINE HYDROCHLORIDE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PATISIRAN | 1 | 0.0004 |
| 1 | SALINE NASAL SPRAY | 1 | 0.0002 |
| 2 | FAM-TRASTUZUMAB DERUXTECAN-NXKI | 2 | 0.0002 |
| 3 | BENDAMUSTINE HYDROCHLORIDE | 1 | 0.0001 |
| 4 | BLEOMYCIN SULFATE | 1 | 0.0001 |
| 5 | PERTUZUMAB | 1 | 0.0000 |
| 6 | VINCRISTINE SULFATE | 1 | 0.0000 |
| 7 | FLUOROURACIL CREAM, 0.5% | 2 | 0.0000 |
| 8 | FLUOROURACIL | 2 | 0.0000 |
| 9 | POTASSIUM CHLORIDE | 2 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Glycopeptide Antibacterial [EPC] | 1 | 0.0000 |
| 1 | HER2/neu Receptor Antagonist [EPC] | 1 | 0.0000 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 3 | 0.0000 |
| 3 | Platinum-based Drug [EPC] | 2 | 0.0000 |
| 4 | alpha-Adrenergic Blocker [EPC] | 1 | 0.0000 |
| 5 | Osmotic Laxative [EPC] | 2 | 0.0000 |
| 6 | Microtubule Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Proton Pump Inhibitor [EPC] | 2 | 0.0000 |
| 8 | beta-Adrenergic Blocker [EPC] | 1 | 0.0000 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |